CELLULAR INTELLIGENCE
Live / Applied — Non-final action mailed (as of 18 Feb 2026)
What this means for you
Not registered yet, but its 14 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99136411
- Mark type
- Stylized text
- Filed
- 14 Apr 2025
- Attorney of record
- Candice M. Kwok
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal preparations for wound healing; Pharmaceutical and medicinal preparations used to promote wound closure and aid in wound healing; Pharmaceutical and medicinal preparations for the treatment of skin inflammation, skin injury and skin damage
Owner
- Eluciderm Inc., San Diego, CA, US
Prosecution history
- 18 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Feb 2026 — NON-FINAL ACTION E-MAILED
- 18 Feb 2026 — NON-FINAL ACTION WRITTEN
- 10 Feb 2026 — USE AMENDMENT ACCEPTED
- 20 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jan 2026 — ASSIGNED TO LIE
- 15 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Jan 2026 — AMENDMENT TO USE PROCESSING COMPLETE
- 13 Jan 2026 — USE AMENDMENT FILED
- 13 Jan 2026 — TEAS AMENDMENT OF USE RECEIVED
- 22 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 22 Oct 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 28 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Jul 2025 — NON-FINAL ACTION E-MAILED